Clinical Trial Update: Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating disitamab vedotin plus carboplatin as first-line treatment for advanced ovarian cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Disitamab Vedotin (disitamab vedotin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Ovarian Cancer, HER2 | Phase 2 | Status: RECRUITING